AVITI LT
LIVE

Serial Number

98143320

Owner

Element Biosciences, Inc.

Attorney

Samantha C. Markley

Filing Date

Aug 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AVITI LT Trademark

Serial Number: 98143320

AVITI LT is a trademark filed by Element Biosciences, Inc. on August 21, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Element Biosciences, Inc. (38 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

August 21, 2023

Registration Date

Not Registered

Published for Opposition

October 8, 2024

Goods & Services

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for use in diagnostic tests for medical purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use

Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings

Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; instruments for scientific use, namely, nucleic acid sequencers, genetic imaging devices and analyzers for genetic analysis

Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, genetic imaging devices and analyzers for genetic analysis

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for laboratory research use; diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for diagnostic laboratory purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 19, 2026 EXRA
SOU EXTENSION 3 GRANTED
May 18, 2026 EX3G
SOU EXTENSION 3 FILED
May 18, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
May 18, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 13, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 13, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 2, 2025 EX1G
SOU EXTENSION 1 FILED
May 2, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 2, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 19, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 30, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 12, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 19, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 19, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 20, 2023 NWOS
NEW APPLICATION ENTERED
Aug 25, 2023 NWAP